M1-type microglia-derived exosomes contribute to blood-brain barrier damage

Wen Jiang1, Yan Wu2, Ailan Pang2

  • 1Department of Neurology, the First Affiliated Hospital of Kunming Medical University, No.295 Xichang Road, Kunming 650032, Yunnan, China; The Yunnan Province Clinical Research Center for Neurological Diseases, No.295 Xichang Road, Kunming 650032, Yunnan, China.

Brain Research
|April 8, 2024
PubMed
Abstract

Insights

Microglia-derived exosomes, particularly from M1-activated cells, damage the blood-brain barrier (BBB) model by altering cell viability and permeability. These exosomes contain microRNAs (miRNAs) that may mediate BBB injury, offering potential therapeutic targets for stroke.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Exosomes facilitate intercellular communication and hold potential for stroke treatment.
  • Activated microglia exacerbate stroke by disrupting the blood-brain barrier (BBB) integrity.

Purpose of the Study:

  • To investigate the impact of microglia-derived exosomes on a BBB cell model.
  • To elucidate the molecular mechanisms underlying exosome-mediated BBB injury.

Main Methods:

  • M1 polarization of BV2 cells induced by LPS; isolation of derived exosomes.
  • Construction of a BBB cell model using astrocytes and End3 cells.
  • Analysis of exosome effects on TEER, permeability, BBB protein expression, and miRNA sequencing.

Main Results:

  • M1-type microglia exosomes decreased cell viability and increased apoptosis in the BBB model.
  • M1-type microglia exosomes enhanced BBB permeability, reduced TEER, and diminished tight junction protein expression.
  • Sequencing identified 71 differentially expressed miRNAs in M1 exosomes targeting neurological pathways.

Conclusions:

  • M1-type microglia-derived exosomes contribute to BBB cell model injury via miRNA involvement.
  • Findings suggest M1 microglia exosomes as potential therapeutic targets for stroke treatment.